1784751-19-4
1784751-19-4
Chemical Structure
TA-02
- CAS No.: 1784751-19-4
- Formula:C20H13F2N3
- Molecular Weight:333.33
IUPAC Name: 4-(2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine
InChIKey: QIFJOFNVIVQRNJ-UHFFFAOYSA-N
SMILES: FC(C=C1)=CC=C1C2=C(C3=CC=NC=C3)NC(C4=CC=CC=C4F)=N2
Biological Activity: TA-02, an analog of SB 203580 (HY-10256), is a p38 MAPK inhibitor with an IC50 of 20 nM. TA-02 especially inhibits TGFBR-2. TA-02 exhibits similar cardiogenic properties as SB 203580 and SB 202190 (HY-10295)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TA-02 | 99.32% | TA-02, an analog of SB 203580 (HY-10256), is a p38 MAPK inhibitor with an IC50 of 20 nM. TA-02 especially inhibits TGFBR-2. TA-02 exhibits similar cardiogenic properties as SB 203580 and SB 202190 (HY-10295). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
TA-02 (Standard) | ≥98% | TA-02 (Standard) is the analytical standard of TA-02 (HY-100115). This product is intended for research and analytical applications. TA-02, an analog of SB 203580 (HY-10256), is a p38 MAPK inhibitor with an IC50 of 20 nM. TA-02 especially inhibits TGFBR-2. TA-02 exhibits similar cardiogenic properties as SB 203580 and SB 202190 (HY-10295). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.85
HY-178209p38 MAP Kinase-IN-3 -
Similarity Score 0.85
HY-100114TA-01 -
Similarity Score 0.83
HY-183530p38 MAPK-IN-11 -
Similarity Score 0.81
HY-111820CK1-IN-1 -
Similarity Score 0.79
HY-10295RSB 202190 (Standard) -
Similarity Score 0.79
HY-180445Glucagon receptor antagonist-10 -
Similarity Score 0.78
HY-10295ASB 202190 hydrochloride -
Similarity Score 0.78
HY-175431p38 MAPK-IN-8 -
Similarity Score 0.78
HY-177156Glucagon receptor antagonist-8 -
Explore the MedChemAI to find more analogs
